These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18299485)

  • 1. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response.
    Fraccarollo D; Galuppo P; Schraut S; Kneitz S; van Rooijen N; Ertl G; Bauersachs J
    Hypertension; 2008 Apr; 51(4):905-14. PubMed ID: 18299485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
    Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a selective aldosterone receptor antagonist in myocardial infarction.
    Delyani JA; Robinson EL; Rudolph AE
    Am J Physiol Heart Circ Physiol; 2001 Aug; 281(2):H647-54. PubMed ID: 11454568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone.
    Fraccarollo D; Galuppo P; Sieweke JT; Napp LC; Grobbecker P; Bauersachs J
    ESC Heart Fail; 2015 Sep; 2(3):150-158. PubMed ID: 28834677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction.
    Masson S; Staszewsky L; Annoni G; Carlo E; Arosio B; Bai A; Calabresi C; Martinoli E; Salio M; Fiordaliso F; Scanziani E; Rudolph AE; Latini R
    J Card Fail; 2004 Oct; 10(5):433-41. PubMed ID: 15470655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone?
    Chai W; Garrelds IM; de Vries R; Danser AH
    Hypertension; 2006 Apr; 47(4):665-70. PubMed ID: 16490840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing.
    Fraccarollo D; Thomas S; Scholz CJ; Hilfiker-Kleiner D; Galuppo P; Bauersachs J
    Hypertension; 2019 Jan; 73(1):102-111. PubMed ID: 30543467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
    Maekawa Y; Anzai T; Yoshikawa T; Sugano Y; Mahara K; Kohno T; Takahashi T; Ogawa S
    J Am Coll Cardiol; 2004 Oct; 44(7):1510-20. PubMed ID: 15464336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
    Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
    Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
    J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling.
    Fraccarollo D; Galuppo P; Bauersachs J; Ertl G
    Cardiovasc Res; 2002 Jun; 54(3):559-67. PubMed ID: 12031701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
    Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
    JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling.
    Kohno T; Anzai T; Naito K; Miyasho T; Okamoto M; Yokota H; Yamada S; Maekawa Y; Takahashi T; Yoshikawa T; Ishizaka A; Ogawa S
    Cardiovasc Res; 2009 Feb; 81(3):565-73. PubMed ID: 18984601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
    Ohtani T; Ohta M; Yamamoto K; Mano T; Sakata Y; Nishio M; Takeda Y; Yoshida J; Miwa T; Okamoto M; Masuyama T; Nonaka Y; Hori M
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R946-54. PubMed ID: 17023667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
    Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
    Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model.
    Kurobe H; Hirata Y; Matsuoka Y; Sugasawa N; Higashida M; Nakayama T; Maxfield MW; Yoshida Y; Shimabukuro M; Kitagawa T; Sata M
    J Surg Res; 2013 Nov; 185(1):455-62. PubMed ID: 23731681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.